Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
548.05
+7.79 (+1.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
76
77
Next >
5 Top Stocks to Buy in June
↗
June 02, 2024
This medley of growth, value, and income stocks is poised to thrive long-term, even if the stock market sells off this summer.
Via
The Motley Fool
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
↗
June 01, 2024
Eli Lilly is in a buy zone, while rival Novo Nordisk forged a lower entry.
Via
Investor's Business Daily
Topics
Stocks
A Very Bullish Reversal Produces A Huge Batch Of Actionable Stocks
↗
May 31, 2024
It is very hard to get excited about what I'm seeing in the stock market because things have not been the way I've wanted them to be. In this video, I want to show you something as we look at a monthly...
Via
Talk Markets
Vertex Stock Recently Hit All-Time High, Leads 8 Top Performers New To IBD Stock Lists
↗
May 31, 2024
Vertex stock was one of a select group of eight that made it onto IBD top-stocks lists Friday. The big pharma is near its all-time high.
Via
Investor's Business Daily
Analyst Expectations For Vertex Pharmaceuticals's Future
↗
May 31, 2024
Via
Benzinga
While growth is established for NASDAQ:VRTX, the stock's valuation remains reasonable.
↗
May 29, 2024
NASDAQ:VRTX is showing decent growth, but is still valued reasonably.
Via
Chartmill
2 Biotech Stocks to Buy in May
↗
May 25, 2024
You could buy these in any month, really.
Via
The Motley Fool
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
↗
May 23, 2024
Via
Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
↗
May 30, 2024
Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat.
Via
The Motley Fool
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
↗
May 28, 2024
Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung function.
Via
Benzinga
Got $500? 3 Pharma Stocks to Buy and Hold Forever
↗
May 26, 2024
These players might even beat the market when the conditions are right.
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
↗
May 26, 2024
Shares of the growing biotech company have doubled in three years.
Via
The Motley Fool
3 High-Flying Stocks That Could Soar Even More
↗
May 25, 2024
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.
Via
The Motley Fool
SLB, First Solar And 2 Other Stocks Insiders Are Selling
↗
May 23, 2024
Via
Benzinga
Should you consider NASDAQ:VRTX for quality investing?
↗
May 22, 2024
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) Exhibits Quality Stock Traits. Here's Why.
Via
Chartmill
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
↗
May 15, 2024
Via
Benzinga
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
↗
May 23, 2024
Walmart Inc. reported a "really strong" quarter, with e-commerce sales surging 21%. Adjusted EPS was 60 cents.
Via
Benzinga
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now
↗
May 23, 2024
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy.
Via
InvestorPlace
Vertex to Participate in Upcoming June Investor Conferences
May 22, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
↗
May 16, 2024
On Thursday, biotech Halozyme Therapeutics stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Via
Investor's Business Daily
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
↗
May 15, 2024
How much would you pay for a stock that might earn $25 a year in six years?
Via
The Motley Fool
Jennifer Schneider Elected to Vertex Board of Directors
May 15, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
↗
May 15, 2024
Pfizer is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform.
Via
Benzinga
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
↗
May 14, 2024
On Tuesday, Catalyst Pharmaceuticals stock hit a key technical milestone, with its Relative Strength Rating climbing to 83 from 79.
Via
Investor's Business Daily
3 Cheap Biotech Stocks to Buy Now: May 2024
↗
May 14, 2024
Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
↗
May 14, 2024
Via
Benzinga
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
↗
May 12, 2024
The biotech's shares dropped following its latest quarterly update, but that shouldn't matter to long-term investors.
Via
The Motley Fool
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
↗
May 12, 2024
These companies are raking in profits at astonishing clips.
Via
The Motley Fool
Stock Market Moves Toward Highs; Arista, Toast, Palantir Key Earnings Movers: Weekly Review
↗
May 10, 2024
Big earnings winners and losers continued.
Via
Investor's Business Daily
Will the Biotech Sector Shift From Lagger to Leader?
May 10, 2024
The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.
Via
MarketBeat
Topics
ETFs
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
76
77
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
